Results 11 to 20 of about 19,913 (173)
Extraintestinal Clostridioides difficile infection
IDCases, 2020 Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai +6 more
doaj +3 more sources
Push Enteroscopic Jejunal and Ileoscopic Delivery of Fecomicrobiota Transplantation (FMT) for Treatment of <i>Clostridioides difficile</i> Enteritis in a Patient With a Total Colectomy and Ileal Pouch-Anal Anastomosis (IPAA): A Case Report. [PDF]
JGH OpenABSTRACT Clostridioides difficile infection (CDI) is recognized as the leading cause of antibiotic‐associated diarrhea. There are several case reports of C. difficile enteritis in patients who have undergone colectomy and end ileostomy or ileal pouch‐anal anastomosis. This case report describes a unique case of recurrent C.
Tan Z, Young E, Rajagopalan A.
europepmc +2 more sources
Clostridioides difficile [PDF]
Trends in Microbiology, 2018 Clostridioides difficile is a spore-forming, anaerobic, intestinal pathogen that causes severe diarrhea that can lead to death. In 2011, C. difficile infected ∼500000 people in the USA and killed ∼29000 people. C. difficile infection (CDI) is the most common healthcare-related infection in the USA, leading to increased healthcare costs of $4.8 billion.
Brindar K, Sandhu, Shonna M, McBride
openaire +2 more sources
Acta Médica Portuguesa, 2022 Introduction: Clostridioides difficile is the main cause of healthcare-associated diarrhea in Europe and North America. The aim of this study was to characterize the epidemiology and clinical burden of Clostridioides difficile infection among ...
Cláudia Nazareth +14 more
doaj +1 more source
Frontiers in Public Health, 2021 Clostridioides difficile infection possesses a significant economical burden, specifically in the inpatient and rural settings. Fecal Microbiota Transplant has been used for treatment of recurrent Clostridioides difficile but its utility is limited by ...
Krishna Vedala +3 more
doaj +1 more source
Clostridioides difficile peptidoglycan modifications
Current Opinion in Microbiology, 2022 The cortex and peptidoglycan of Clostridioides difficile have been poorly investigated. This last decade, the interest increased because these two structures are highly modified and these modifications may be involved in antimicrobial resistance. For example, C.
Coullon, Héloïse, Candela, Thomas
openaire +4 more sources
Plasmids of Clostridioides difficile
Current Opinion in Microbiology, 2022 Plasmids are ubiquitous in the bacterial world. In many microorganisms, plasmids have been implicated in important aspects of bacterial physiology and contribute to horizontal gene transfer. In contrast, knowledge on plasmids of the enteropathogen Clostridioides difficile is limited, and there appears to be no phenotypic consequence to carriage of many
Smits, W.K., Roseboom, A.M., Corver, J.
openaire +3 more sources
Clostridioides Difficile Enteritis: Case Report and Literature Review
Antibiotics, 2022 Background: Clostridioides Difficile is a well-known pathogen causing diarrhea of various degrees of severity through associated infectious colitis.
Artsiom Klimko +6 more
doaj +1 more source
Analysis of the impact of secondary prophylaxis on recurrence in critically ill adults
SAGE Open Medicine, 2020 Introduction: Clostridioides (formerly Clostridium ) difficile infection recurrence in patients re-exposed to antibiotics for treatment of a non- Clostridioides difficile infection is high at approximately 33%. Low-dose per os vancomycin (e.g. 125 mg q12
Kathryn A Connor, Kelly M Conn
doaj +1 more source